Traded Oct 20, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Oct 6, 2025 · Filed Oct 15, 2025
A 10% owner of Spruce Biosciences paid $4.6K out of pocket for Spruce Biosciences shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$4,585
Shares × reported transaction price
<$25K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
53 days after results of Aug 14, 2025, 35 days before results of Nov 10, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded Oct 20, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Oct 20, 2025 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Oct 20, 2025 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.